HIGH WIRE NETWORKS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HIGH WIRE NETWORKS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $8.38M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $6.91M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $26.77M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $27.21M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.91M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $25.50M | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $34.55M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $5.87M | Mar 26, 2019 |
| FY2018 | May 31, 2017 | $1.07M | Mar 26, 2019 |
| FY2017 | May 31, 2016 | $70.3K | Sep 26, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | May 31, 2017 | $249.4K | Sep 26, 2017 |
| FY2017 | May 31, 2016 | $70.3K | Sep 26, 2017 |
| FY2016 | May 31, 2015 | $198.9K | Sep 30, 2016 |
| FY2015 | May 31, 2014 | $274.6K | Sep 18, 2015 |
| FY2014 | May 31, 2013 | $527 | Sep 15, 2014 |
| FY2013 | May 31, 2012 | $3.0K | Sep 13, 2013 |
| FY2012 | May 31, 2011 | $371 | Sep 13, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($384.8K) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($14.49M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($19.04M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($13.68M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($693.1K) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($5.83M) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($1.29M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.80M) | Mar 26, 2019 |
| FY2018 | May 31, 2017 | ($6.81M) | Mar 26, 2019 |
| FY2017 | May 31, 2016 | ($2.18M) | Sep 26, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($8.55M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($11.95M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($13.10M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($3.67M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.44M) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.49M) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($2.54M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($1.20M) | Mar 26, 2019 |
| FY2018 | May 31, 2017 | ($4.76M) | Mar 26, 2019 |
| FY2016 | May 31, 2016 | ($852.6K) | Sep 30, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | May 31, 2016 | $137.6K | Sep 30, 2016 |
| FY2016 | May 31, 2015 | $698.6K | Sep 30, 2016 |
| FY2015 | May 31, 2014 | $396.3K | Sep 18, 2015 |
| FY2014 | May 31, 2013 | $428.7K | Sep 15, 2014 |
| FY2013 | May 31, 2012 | $11.6K | Sep 13, 2013 |
| FY2012 | May 31, 2011 | $0 | Sep 13, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($6.13M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($7.93M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($2.12M) | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | ($4.21M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($532.7K) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($2.28M) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($1.49M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($551.6K) | Mar 26, 2019 |
| FY2018 | May 31, 2017 | ($403.7K) | Mar 26, 2019 |
| FY2017 | May 31, 2016 | ($463.4K) | Sep 26, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $14.0K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $20.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $404.7K | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $93.3K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $115.3K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $7.8K | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $21.3K | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $3.6K | Mar 26, 2019 |
| FY2017 | May 31, 2016 | $4.6K | Sep 26, 2017 |
| FY2016 | May 31, 2015 | ($28.3K) | Sep 30, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.79M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $10.83M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $32.59M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $45.96M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $7.66M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $12.17M | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $12.93M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.51M | Mar 26, 2019 |
| FY2017 | May 31, 2017 | $5.19M | Sep 26, 2017 |
| FY2017 | May 31, 2016 | $171.0K | Sep 26, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.64M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $13.58M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $26.85M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $34.81M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $4.95M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $16.12M | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $17.53M | May 14, 2020 |
| FY2017 | May 31, 2017 | $9.97M | Sep 26, 2017 |
| FY2017 | May 31, 2016 | $2.85M | Sep 26, 2017 |
| FY2016 | May 31, 2015 | $1.52M | Sep 30, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.85M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($2.75M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2022 | ($11.72M) | Mar 31, 2025 |
| FY2022 | Dec 31, 2021 | ($4.39M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.10M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($5.44M) | Apr 1, 2021 |
| FY2020 | Dec 31, 2018 | ($5.69M) | Apr 1, 2021 |
| FY2018 | Dec 31, 2017 | ($6.34M) | Mar 26, 2019 |
| FY2017 | May 31, 2017 | ($4.72M) | Sep 26, 2017 |
| FY2017 | May 31, 2016 | ($2.44M) | Sep 26, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $605.6K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $3.16M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $8.03M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | $21.70M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.73M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $331.2K | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.83M | May 14, 2020 |
| FY2018 | Dec 31, 2017 | $1.50M | Mar 26, 2019 |
| FY2017 | May 31, 2017 | $1.50M | Sep 26, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($46.93M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($46.55M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($32.06M) | Apr 19, 2024 |
| FY2020 | Dec 31, 2020 | ($48.20M) | Apr 1, 2021 |
| FY2020 | Dec 31, 2019 | ($30.49M) | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | ($24.17M) | May 14, 2020 |
| FY2018 | Dec 31, 2017 | ($22.32M) | Mar 26, 2019 |
| FY2017 | May 31, 2017 | ($20.52M) | Sep 26, 2017 |
| FY2017 | May 31, 2016 | ($13.71M) | Sep 26, 2017 |
| FY2016 | May 31, 2015 | ($11.53M) | Sep 30, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $220.8K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $333.4K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $649.0K | Apr 19, 2024 |
| FY2021 | Dec 31, 2020 | $184.7K | Apr 15, 2022 |
| FY2021 | Dec 31, 2019 | $504.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2018 | $585.2K | Apr 1, 2021 |
| FY2019 | Dec 31, 2017 | $28.9K | May 14, 2020 |
| FY2018 | Sep 30, 2017 | $19.3K | Mar 26, 2019 |
| FY2018 | May 31, 2017 | $345.1K | Mar 26, 2019 |
| FY2018 | Dec 31, 2016 | $1.1K | Mar 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 23, 2022 | $0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2021 | $191.4K | Apr 15, 2022 |
| FY2020 | Dec 31, 2020 | $532.4K | Apr 1, 2021 |
| FY2020 | Dec 31, 2019 | $3.80M | Apr 1, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | (15) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 19, 2024 |
| FY2021 | Dec 31, 2021 | (1) | Apr 15, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | (15) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Apr 17, 2023 |
| FY2015 | May 31, 2015 | 0 | Sep 18, 2015 |
| FY2015 | May 31, 2014 | 0 | Sep 18, 2015 |
| FY2014 | May 31, 2013 | 0 | Sep 15, 2014 |
| FY2013 | May 31, 2012 | 0 | Sep 13, 2013 |
| FY2012 | May 31, 2011 | 0 | Sep 13, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 970,319 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 959,508 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 164.49M | Apr 19, 2024 |
| FY2022 | Dec 31, 2021 | 46.15M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 1,754 | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 193,644 | Apr 1, 2021 |
| FY2019 | Dec 31, 2018 | 23,632 | May 14, 2020 |
| FY2018 | Dec 31, 2017 | 2.12M | Mar 26, 2019 |
| FY2017 | May 31, 2017 | 275.00M | Sep 26, 2017 |
| FY2017 | May 31, 2016 | 88.56M | Sep 26, 2017 |